Browsing by Author Zhang, Yongchang

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China
Journal:Cancer Immunology, Immunotherapy
Yan, HuanSong, LianxiLi, YizhiXu, QinqinGuo, WenhuanLin, ShaodingJiang, WenjuanWang, ZhanDeng, LiHuang, ZheQin, HaoyueZhang, XingTong, FanZhang, RuiguangLiu, ZhaoyiZhang, LinYu, JuanDong, XiaorongGong, QianDeng, JunChen, XueWang, JingZhang, GaoYang, NongZhang, YongchangZeng, Liang
7-Mar-2024
 
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study
Journal:Lung Cancer
Huang, ZheZhang, YudaXu, QinqinSong, LianxiLi, YizhiGuo, WenhuanLin, ShaodingJiang, WenjuanWang, ZhanDeng, LiQin, HaoyueZhang, XingTong, FanZhang, RuiguangLiu, ZhaoyiZhang, LinYu, JuanDong, XiaorongGong, QianDeng, JunChen, XueWang, JingZhang, GaoYang, NongZeng, LiangZhang, Yongchang
20-May-2024
 
Intrathecal nivolumab and IL-2 for treatment of leptomeningeal metastases in EGFR-mutated lung adenocarcinoma
Journal:Lung Cancer
Ruan, ZhaohuiZeng, LiangZhang, JinQin, HaoyueHuang, ZheYan, HuanZhang, GaoZhang, Yongchang
18-May-2025
 
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
Journal:Med
Zeng, LiangYan, HuanJiang, WenjuanQin, HaoyueDai, JiachengZhang, YudaWei, ShiyouChen, ShanmeiLiu, LiXiong, YiYang, HaiyanLi, YizhiWang, ZhanDeng, LiXu, QinqinPeng, LingZhang, RuiguangFang, ChaoChen, XueDeng, JunWang, JingLi, TingLiu, HongZhang, GaoYang, NongZhang, Yongchang
31-Jan-2025
Showing results 1 to 4 of 4